Dynamic ultrasound molecular‐targeted imaging of senescence in evaluation of lapatinib resistance in HER2‐positive breast cancer

BACKGROUND: Prolonged treatment of HER2+ breast cancer with lapatinib (LAP) causes cellular senescence and acquired drug resistance, which often associating with poor prognosis for patients. We aim to explore the correlation between cellular senescence and LAP resistance in HER2+ breast cancer, scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoyu, Li, Ying, Zhou, Zhiwei, Zhang, Yanqiu, Chang, Luchen, Gao, Xiujun, Li, Qing, Luo, Hao, Westover, Kenneth D., Zhu, Jialin, Wei, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587953/
https://www.ncbi.nlm.nih.gov/pubmed/37792675
http://dx.doi.org/10.1002/cam4.6607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587953/
https://www.ncbi.nlm.nih.gov/pubmed/37792675
http://dx.doi.org/10.1002/cam4.6607

Ejemplares similares